Thursday, 29 September 2016

New Report Explores on Global Total Artificial Heart(TAH)Market 2016

Global Total Artificial Heart(TAH)Market Research Report 2016 is a new market research publication announced by Reportstack. This report studies Total Artificial Heart (TAH) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering 
Baxter International, Inc. (USA) 
Abbott Diabetes Care, Inc. (USA) 
Vital Therapies, Inc. (USA) 
Xenios AG (Germany) 
Asahi Kasei Medical Co., Ltd. (Japan) 
Medtronic, Inc. (USA) 
HeartWare International, Inc. (USA) 
Fresenius Medical Care AG & Co. KGaA (Germany) 
Jarvik Heart, Inc. (USA) 
Toray Medical Co., Ltd. (Japan) 
Nikkiso Co., Ltd. (Japan) 
Nipro Corporation (Japan) 
SynCardia Systems, Inc. (USA) 
Terumo Heart, Inc. (USA) 
Thoratec Corp. (USA) 
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Total Artificial Heart (TAH) in these regions, from 2011 to 2021 (forecast), like 
North America 
Europe 
China 
Japan 
Southeast Asia 
India 
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I 
Type II 
Type III 
Split by application, this report focuses on consumption, market share and growth rate of Total Artificial Heart (TAH) in each application, can be divided into 
Application 1 
Application 2 
Application 3
Snapshot of TOC with Companies Mentioned
7 Global Total Artificial Heart (TAH) Manufacturers Profiles/Analysis 
7.1 Baxter International, Inc. (USA) 
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors 
7.1.2 Total Artificial Heart (TAH) Product Type, Application and Specification 
7.1.2.1 Type I 
7.1.2.2 Type II 
7.1.3 Baxter International, Inc. (USA) Total Artificial Heart (TAH) Production, Revenue, Price and Gross Margin (2015 and 2016) 
7.1.4 Main Business/Business Overview 
7.2 Abbott Diabetes Care, Inc. (USA) 
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors 
7.2.2 Total Artificial Heart (TAH) Product Type, Application and Specification 
7.2.2.1 Type I 
7.2.2.2 Type II 
7.2.3 Abbott Diabetes Care, Inc. (USA) Total Artificial Heart (TAH) Production, Revenue, Price and Gross Margin (2015 and 2016) 
7.2.4 Main Business/Business Overview 
7.3 Vital Therapies, Inc. (USA) 
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors 
7.3.2 Total Artificial Heart (TAH) Product Type, Application and Specification 
7.3.2.1 Type I 
7.3.2.2 Type II 
7.3.3 Vital Therapies, Inc. (USA) Total Artificial Heart (TAH) Production, Revenue, Price and Gross Margin (2015 and 2016) 
7.3.4 Main Business/Business Overview 
7.4 Xenios AG (Germany) 
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors 
7.4.2 Total Artificial Heart (TAH) Product Type, Application and Specification 
7.4.2.1 Type I 
7.4.2.2 Type II 
7.4.3 Xenios AG (Germany) Total Artificial Heart (TAH) Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview 
7.5 Asahi Kasei Medical Co., Ltd. (Japan) 
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors 
7.5.2 Total Artificial Heart (TAH) Product Type, Application and Specification 
7.5.2.1 Type I 
7.5.2.2 Type II 
7.5.3 Asahi Kasei Medical Co., Ltd. (Japan) Total Artificial Heart (TAH) Production, Revenue, Price and Gross Margin (2015 and 2016) 
7.5.4 Main Business/Business Overview 
7.6 Medtronic, Inc. (USA) 
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors 
7.6.2 Total Artificial Heart (TAH) Product Type, Application and Specification 
7.6.2.1 Type I 
7.6.2.2 Type II 
7.6.3 Medtronic, Inc. (USA) Total Artificial Heart (TAH) Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview 
7.7 HeartWare International, Inc. (USA) 
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors 
7.7.2 Total Artificial Heart (TAH) Product Type, Application and Specification 
7.7.2.1 Type I 
7.7.2.2 Type II 
7.7.3 HeartWare International, Inc. (USA) Total Artificial Heart (TAH) Production, Revenue, Price and Gross Margin (2015 and 2016) 
7.7.4 Main Business/Business Overview 
7.8 Fresenius Medical Care AG & Co. KGaA (Germany) 
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors 
7.8.2 Total Artificial Heart (TAH) Product Type, Application and Specification 
7.8.2.1 Type I 
7.8.2.2 Type II 
7.8.3 Fresenius Medical Care AG & Co. KGaA (Germany) Total Artificial Heart (TAH) Production, Revenue, Price and Gross Margin (2015 and 2016) 
7.8.4 Main Business/Business Overview 
7.9 Jarvik Heart, Inc. (USA) 
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors 
7.9.2 Total Artificial Heart (TAH) Product Type, Application and Specification 
7.9.2.1 Type I 
7.9.2.2 Type II 
7.9.3 Jarvik Heart, Inc. (USA) Total Artificial Heart (TAH) Production, Revenue, Price and Gross Margin (2015 and 2016) 
7.9.4 Main Business/Business Overview 
7.10 Toray Medical Co., Ltd. (Japan) 
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors 
7.10.2 Total Artificial Heart (TAH) Product Type, Application and Specification 
7.10.2.1 Type I 
7.10.2.2 Type II 
7.10.3 Toray Medical Co., Ltd. (Japan) Total Artificial Heart (TAH) Production, Revenue, Price and Gross Margin (2015 and 2016) 
7.10.4 Main Business/Business Overview 
7.11 Nikkiso Co., Ltd. (Japan) 
7.12 Nipro Corporation (Japan) 
7.13 SynCardia Systems, Inc. (USA) 
7.14 Terumo Heart, Inc. (USA) 
7.15 Thoratec Corp. (USA)
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)